Early TNF Inhibitor Initiation in Ankylosing Spondylitis Linked to Increase Cardiovascular Risk

November 15th 2022, 10:25pm


Results indicate early initiation of tumor necrosis factor (TNF) inhibitors in a veterans population was associated with a 17% increase in incident cardiovascular disease and a 22% increase in major events.

While Mortality Wanes for RA, Patients Still at Higher Risk of All-Cause Mortality

November 11th 2022, 8:15pm


The observational study found that 25% of deaths were premature and that mortality associated with rheumatoid arthritis (RA) resulted from cardiovascular, cancer, and respiratory causes

EULAR Updates Therapy Recommendations for RA

November 11th 2022, 11:30am


The latest update says that Janus kinase (JAK) inhibitors should only be used if risk factors for cardiovascular disease or cancer have been considered, and that biologics are preferred.

Study Supports Feasibility of Integrating Specialty Pharmacists in Health Systems

October 30th 2022, 1:15pm


The program, serving patients from rheumatology, dermatology, gastroenterology, allergy, and cardiology clinics, is the first of its kind within the Veterans Health Administration, researchers said.

Adding Machine Learning to Longitudinal PRO Data May Prove Useful in RA

October 24th 2022, 3:44pm


In a proof-of-concept analysis, researchers show that machine learning methods paired with longitudinal patient-reported outcomes (PRO) data were able to classify subsequent rheumatoid arthritis (RA) disease activity after beginning treatment with a biologic

Researchers Highlight Importance of Assessing Osteoporosis Risk Factors in RA

October 15th 2022, 11:16pm


Risk of osteoporosis and bone fractures in rheumatoid arthritis (RA) stem from disease-specific causes, disease treatment, and factors that face the general population, according to researchers, who highlighted the importance of assessing risk factors in these patients.

Pulmonary Abnormalities Observed in 70% of Patients With RA in Study

October 15th 2022, 10:00pm


Though typically associated with effects on the joints, rheumatoid arthritis (RA) was found have a pulmonary effect in nearly 3 in 4 patients included in the retrospective, single-center study.

Study of IL-17A Treatment Underscores Potential of circRNA as Biomarker in Psoriasis

October 8th 2022, 1:43pm


The study, which assessed changes in circRNA and miRNA after beginning treatment with secukinumab, revealed a prompt change in circRNA abundance upon initiation of treatment and a strong correlation between circRNA and the psoriasis area and severity index.

Patients With RA Face Higher Risk of COVID-19, Hospitalization Even When Vaccinated

October 7th 2022, 3:30pm


Based on their findings, the researchers are emphasizing the importance of patients with rheumatoid arthritis (RA) receiving a booster vaccination, as well as other mitigation strategies, such as social distancing and wearing face masks.

Tocilizumab Leads to Improvement in Patients With Active Polymyalgia Rheumatica Despite Prednisone Therapy

September 25th 2022, 1:32pm


However, patient-reported scores were not significantly better in the tocilizumab group.